ArticleThe Lancet regional health. Europe2024

Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trial.

Inge J M H Caelers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.